Balyasny Asset Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-100,246
Closed -$6.9M 3047
2024
Q2
$6.9M Buy
100,246
+73,811
+279% +$5M 0.01% 1027
2024
Q1
$1.92M Sell
26,435
-30,996
-54% -$2.07M ﹤0.01% 1552
2023
Q4
$3.52M Buy
+57,431
New +$3.41M 0.01% 1256
2023
Q1
Sell
-18,110
Closed -$1.13M 3023
2022
Q4
$1.13M Buy
+18,110
New +$1.04M ﹤0.01% 1610
2020
Q2
Sell
-24,122
Closed -$885K 1404
2020
Q1
$885K Buy
24,122
+3,975
+20% +$154K 0.01% 788
2019
Q4
$816K Buy
20,147
+1,291
+7% +$48.2K ﹤0.01% 918
2019
Q3
$654K Buy
+18,856
New +$621K ﹤0.01% 905
2019
Q1
Sell
-9,738
Closed -$301K 1583
2018
Q4
$301K Sell
9,738
-221,039
-96% -$8.07M ﹤0.01% 1229
2018
Q3
$8.74M Buy
230,777
+202,471
+715% +$7.66M 0.04% 533
2018
Q2
$1.09M Buy
+28,306
New +$954K ﹤0.01% 1097
2018
Q1
Sell
-22,269
Closed -$989K 2233
2017
Q4
$989K Buy
+22,269
New +$1.01M ﹤0.01% 1335
2017
Q2
Sell
-5,788
Closed -$322K 1667
2017
Q1
$322K Sell
5,788
-2,587
-31% -$143K ﹤0.01% 1390
2016
Q4
$436K Buy
8,375
+897
+12% +$43.3K ﹤0.01% 1183
2016
Q3
$361K Sell
7,478
-980
-12% -$49.6K ﹤0.01% 787
2016
Q2
$469K Buy
8,458
+2,280
+37% +$126K ﹤0.01% 834
2016
Q1
$330K Buy
6,178
+2,190
+55% +$108K ﹤0.01% 988
2015
Q4
$205K Buy
+3,988
New +$198K ﹤0.01% 1087
2014
Q2
Sell
-12,086
Closed -$329K 744
2014
Q1
$329K Buy
+12,086
New +$359K ﹤0.01% 544

Other funds holding PBH

Balyasny Asset Management's PBH Position: Q3 2024 in Review

Balyasny Asset Management sold out of Prestige Consumer Healthcare (PBH) in Q3 2024, closing a stake of 100,246 shares — an estimated $6.9M sold.

Balyasny Asset Management first reported a position in PBH in Q1 2014 and held it in 18 quarters. The position peaked at $8.74M in Q3 2018. 328 funds tracked by Wall St. Rank hold PBH as of Q3 2024.

  • Balyasny Asset Management reported no remaining Prestige Consumer Healthcare position as of Q3 2024 after selling out during the quarter.
  • Balyasny Asset Management sold 100,246 Prestige Consumer Healthcare shares in Q3 2024, an estimated $6.9M.
  • Balyasny Asset Management first reported a position in Prestige Consumer Healthcare in Q1 2014 and held it in 18 quarters.
  • Balyasny Asset Management's Prestige Consumer Healthcare position peaked at $8.74M in Q3 2018.
  • 328 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2024.

Based on Balyasny Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.